RWE Raises FY21 Earnings Forecast

RWE Aktiengesellschaft (RWEOY.PK), on Friday, said it has revised its financial guidance for the full year 2021.

The company now expects 2021 adjusted EBITDA to be in the range of EUR3.0 billion - EUR3.4 billion, compared to the previously communicated range of EUR2.65 billion to EUR3.05 billion.

Adjusted EBITDA of the core business is projected to range between EUR2.15 billion and EUR2.55 billion, up from the prior guidance range of EUR1.8 billion - EUR2.2 billion.

Further, the company lifted its fiscal 2021 adjusted EBIT to EUR1.5 billion - EUR1.9 billion from the prior expectation of EUR1.15 billion - EUR1.55 billion and adjusted net income outlook to EUR1.05 billion - EUR1.40 billion from the prior guidance range of EUR0.75 billion - EUR1.10 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
Follow RTT